Genetic testing pioneer 23andMe is looking at strategic alternatives, including a possible sale, it said Tuesday, months ...

23andMe said it's started exploring strategic alternatives, including a possible sale. The company released third-quarter ...

Aaron Hirschhorn wasn't just promoting another pet product when he took the Shark Tank stage in season 11. He was proposing a ground-breaking idea that would permanently alter veterinary care.

CEO Anne Wojcicki last spring proposed buying out the company and taking it private. From the San Francisco Business Times: Genetic testing pioneer 23andMe is looking at strategic alternatives ...

Shares in 23andMe are currently trading at around $3.40, giving it a valuation of just under $82 million. The company went ...

23andMe CEO Anne Wojcicki sounded optimistic about the company's future during an earnings call in February last year. She said the biotech company, which offers direct-to-consumer genetic testing ...

After detailed negotiations on episode 11, guest Shark Anne Wojcicki and Lori Greiner offered a joint investment of $500,000 for 5% equity. Before appearing on the show, the company had secured $ ...

23andMe Holding Co. ( ME, Financials) announced that its board's Special Committee is reviewing strategic alternatives, ...

23andMe faced major hurdles in 2024, including a $30 million settlement related to compromised data. 23andMe is now restructuring its business operations to reduce costs and streamline operations.

A 23andMe spokesperson said the company is "consistently focused on maintaining the privacy of our customers." 23andMe CEO Anne Wojcicki sounded optimistic about the company's future during an ...